tiprankstipranks
IRLAB Therapeutics AB Class A (SE:IRLAB.A)
:IRLAB.A
Sweden Market
IRLAB.A
IRLAB Therapeutics AB Class A
RESEARCH TOOLSreports
Want to see SE:IRLAB.A full AI Analyst Report?

IRLAB Therapeutics AB Class A (IRLAB.A) Balance Sheet

1 Followers

IRLAB Therapeutics AB Class A Balance Sheet

IRLAB Therapeutics AB Class A's total assets for Q1 2026 were kr135.03M, a decrease of -2.30% from the previous quarter. SE:IRLAB.A total liabilities were kr95.19M for the fiscal quarter, a -11.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
kr 138.21Mkr 136.21Mkr 177.12Mkr 323.56Mkr 472.45M
Total Liabilities
kr 107.49Mkr 103.58Mkr 61.36Mkr 32.72Mkr 72.97M
Total Equity Gross Minority
kr 30.72Mkr 32.63Mkr 115.76Mkr 290.83Mkr 399.48M
Other Metrics
Currency in SEK

IRLAB Therapeutics AB Class A Debt to Assets